BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38562769)

  • 1. Integrative spatial omics reveals distinct tumor-promoting multicellular niches and immunosuppressive mechanisms in African American and European American patients with TNBC.
    Zhu Q; Balasubramanian A; Asirvatham JR; Piyarathna DWB; Kaur J; Mohamed N; Wu L; Chatterjee M; Wang S; Pourfarrokh N; Rasaily U; Xu Y; Zheng J; Jebakumar D; Rao A; Chen SH; Li Y; Chang E; Li X; Aneja R; Zhang XH; Sreekumar A
    bioRxiv; 2024 Mar; ():. PubMed ID: 38562769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial Disparities in Triple Negative Breast Cancer: A Review of the Role of Biologic and Non-biologic Factors.
    Prakash O; Hossain F; Danos D; Lassak A; Scribner R; Miele L
    Front Public Health; 2020; 8():576964. PubMed ID: 33415093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular phenotypes in triple negative breast cancer from African American patients suggest targets for therapy.
    Lindner R; Sullivan C; Offor O; Lezon-Geyda K; Halligan K; Fischbach N; Shah M; Bossuyt V; Schulz V; Tuck DP; Harris LN
    PLoS One; 2013; 8(11):e71915. PubMed ID: 24260093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LXR/RXR pathway signaling associated with triple-negative breast cancer in African American women.
    Torres-Luquis O; Madden K; N'dri NM; Berg R; Olopade OF; Ngwa W; Abuidris D; Mittal S; Lyn-Cook B; Mohammed SI
    Breast Cancer (Dove Med Press); 2019; 11():1-12. PubMed ID: 30588086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial Disparity and Triple-Negative Breast Cancer in African-American Women: A Multifaceted Affair between Obesity, Biology, and Socioeconomic Determinants.
    Siddharth S; Sharma D
    Cancers (Basel); 2018 Dec; 10(12):. PubMed ID: 30558195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative assessment of the immune microenvironment in African American Triple Negative Breast Cancer: a case-control study.
    Yaghoobi V; Moutafi M; Aung TN; Pelekanou V; Yaghoubi S; Blenman K; Ibrahim E; Vathiotis IA; Shafi S; Sharma A; O'Meara T; Fernandez AI; Pusztai L; Rimm DL
    Breast Cancer Res; 2021 Dec; 23(1):113. PubMed ID: 34906209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of immunosuppressive signature subtypes and prognostic risk signatures in triple-negative breast cancer.
    Ding R; Wang Y; Fan J; Tian Z; Wang S; Qin X; Su W; Wang Y
    Front Oncol; 2023; 13():1108472. PubMed ID: 37377907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethnic disparities in the immune microenvironment of triple negative breast cancer and its role in therapeutic outcomes.
    Zajac KK; Malla S; Babu RJ; Raman D; Tiwari AK
    Cancer Rep (Hoboken); 2023 Sep; 6 Suppl 1(Suppl 1):e1779. PubMed ID: 36632988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PLK1 and AURKB phosphorylate survivin differentially to affect proliferation in racially distinct triple-negative breast cancer.
    Garlapati C; Joshi S; Bhattarai S; Krishnamurthy J; Turaga RC; Nguyen T; Li X; Aneja R
    Cell Death Dis; 2023 Jan; 14(1):12. PubMed ID: 36627281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular profiling of a real-world breast cancer cohort with genetically inferred ancestries reveals actionable tumor biology differences between European ancestry and African ancestry patient populations.
    Miyashita M; Bell JSK; Wenric S; Karaesmen E; Rhead B; Kase M; Kaneva K; De La Vega FM; Zheng Y; Yoshimatsu TF; Khramtsova G; Liu F; Zhao F; Howard FM; Nanda R; Beaubier N; White KP; Huo D; Olopade OI
    Breast Cancer Res; 2023 May; 25(1):58. PubMed ID: 37231433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the JNK-Active Triple-Negative Breast Cancer Cluster Associated With an Immunosuppressive Tumor Microenvironment.
    Semba T; Wang X; Xie X; Cohen EN; Reuben JM; Dalby KN; Long JP; Phi LTH; Tripathy D; Ueno NT
    J Natl Cancer Inst; 2022 Jan; 114(1):97-108. PubMed ID: 34250544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune microenvironment of triple-negative breast cancer in African-American and Caucasian women.
    O'Meara T; Safonov A; Casadevall D; Qing T; Silber A; Killelea B; Hatzis C; Pusztai L
    Breast Cancer Res Treat; 2019 May; 175(1):247-259. PubMed ID: 30725384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myc mediates cancer stem-like cells and EMT changes in triple negative breast cancers cells.
    Yin S; Cheryan VT; Xu L; Rishi AK; Reddy KB
    PLoS One; 2017; 12(8):e0183578. PubMed ID: 28817737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of microRNA between triple negative breast cancer patients of African American and European American descent.
    MacCuaig WM; Thomas A; Claros-Sorto JC; Gomez-Gutierrez JG; Alexander AC; Wellberg EA; Grizzle WE; McNally LR
    Biotech Histochem; 2022 Jan; 97(1):1-10. PubMed ID: 34979848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevation of Stromal-Derived Mediators of Inflammation Promote Prostate Cancer Progression in African-American Men.
    Gillard M; Javier R; Ji Y; Zheng SL; Xu J; Brendler CB; Crawford SE; Pierce BL; Griend DJV; Franco OE
    Cancer Res; 2018 Nov; 78(21):6134-6145. PubMed ID: 30181178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unraveling Triple-Negative Breast Cancer Tumor Microenvironment Heterogeneity: Towards an Optimized Treatment Approach.
    Bareche Y; Buisseret L; Gruosso T; Girard E; Venet D; Dupont F; Desmedt C; Larsimont D; Park M; Rothé F; Stagg J; Sotiriou C
    J Natl Cancer Inst; 2020 Jul; 112(7):708-719. PubMed ID: 31665482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The persisting puzzle of racial disparity in triple negative breast cancer: looking through a new lens.
    Garlapati C; Joshi S; Sahoo B; Kapoor S; Aneja R
    Front Biosci (Schol Ed); 2019 Mar; 11(1):75-88. PubMed ID: 30844737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant activation of GLI1 and Notch1 contributes to racial disparity of human triple negative breast cancer progression.
    Siddharth S; Parida S; Muniraj N; Hercules S; Lim D; Nagalingam A; Wang C; Gyorffy B; Daniel JM; Sharma D
    Elife; 2021 Dec; 10():. PubMed ID: 34889737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic, epigenomic, and transcriptomic signatures of prostate cancer between African American and European American patients.
    Stevens C; Hightower A; Buxbaum SG; Falzarano SM; Rhie SK
    Front Oncol; 2023; 13():1079037. PubMed ID: 36937425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neighborhood Social Determinants of Triple Negative Breast Cancer.
    Hossain F; Danos D; Prakash O; Gilliland A; Ferguson TF; Simonsen N; Leonardi C; Yu Q; Wu XC; Miele L; Scribner R
    Front Public Health; 2019; 7():18. PubMed ID: 30834239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.